| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 24 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 22 |
| 2 | TACROLIMUS OINTMENT 0.1% | 22 |
| 3 | IBUPROFEN | 21 |
| 4 | RITUXIMAB | 17 |
| 5 | IBUPFROFEN | 16 |
| 6 | IBUPROFEN 200 MG | 16 |
| 7 | IBUPROFEN 200MG | 16 |
| 8 | IBUPROFEN CAPSULE | 16 |
| 9 | IBUPROFEN CAPSULES 200 MG | 16 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PROTEIN C CONCENTRATE HUMAN | 2 | 0.0250 |
| 1 | CROVALIMAB | 1 | 0.0083 |
| 2 | LINCOMYCIN HYDROCHLORIDE | 1 | 0.0034 |
| 3 | ANGIOTENSIN II | 1 | 0.0033 |
| 4 | SILTUXIMAB | 2 | 0.0031 |
| 5 | ANIDULAFUNGIN | 3 | 0.0018 |
| 6 | SODIUM THIOSULFATE | 1 | 0.0018 |
| 7 | KETOROLAC TROMETHAMINE | 8 | 0.0016 |
| 8 | PROPYLTHIOURACIL | 2 | 0.0010 |
| 9 | VANCOMYCIN HYDROCHLORIDE | 8 | 0.0010 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Complement C5 Inhibitor [EPC] | 1 | 0.0083 |
| 1 | Vasoconstrictor [EPC] | 1 | 0.0033 |
| 2 | Interleukin-6 Antagonist [EPC] | 2 | 0.0031 |
| 3 | Opioid Antagonist [EPC] | 1 | 0.0010 |
| 4 | alpha-1 Adrenergic Agonist [EPC] | 2 | 0.0005 |
| 5 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 6 | Erythroid Maturation Agent [EPC] | 1 | 0.0004 |
| 7 | Echinocandin Antifungal [EPC] | 3 | 0.0004 |
| 8 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 4 | 0.0003 |
| 9 | Interleukin-1 Receptor Antagonist [EPC] | 4 | 0.0002 |